Laser Therapy for Burn Scars
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the effectiveness of fractional vascular laser therapy in improving burn scars. The goal is to determine if this laser treatment can make scars flatter, smoother, less red, and more flexible. It targets individuals with burn scars that are 6 to 12 months old, located on the trunk or arms and legs. Participants should reside in Winnipeg and have lighter skin tones, defined as Fitzpatrick skin types I-III. The trial includes two groups: one with scars closer to the heart and another with scars farther from the heart. As an unphased trial, this study allows participants to contribute to innovative research that could enhance future burn scar treatments.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this laser therapy is safe for burn scars?
Research has shown that fractional vascular lasers are generally safe for treating burn scars. Studies have found these lasers effective and well-tolerated. For example, one study found that using a fractional CO2 laser improved scar thickness and symptoms without causing major side effects. Another study reported that fractional laser resurfacing is safe for scars from burns and injuries, indicating that serious problems or complications are rare with this treatment. Overall, evidence suggests that fractional vascular lasers offer a promising option for improving the appearance of burn scars.12345
Why are researchers excited about this trial?
Fractional Vascular Laser therapy is unique because it targets burn scars using precise laser technology. Unlike traditional treatments like topical creams or surgical procedures, which often focus on managing symptoms or removing scar tissue, this laser therapy directly affects blood vessels within the scar tissue, potentially improving healing and appearance. Researchers are excited about this method because it offers a non-invasive approach that can be finely tuned to the specific needs of different scar locations, such as distal or proximal areas relative to the heart, promising more personalized and effective outcomes.
What evidence suggests that fractional vascular laser therapy is effective for improving burn scars?
Research has shown that fractional CO2 laser therapy, studied in this trial as Fractional Vascular Laser, can improve burn scars. Studies have found that this treatment smooths scars, reduces their height, and aids in better skin healing. Many patients report less pain and itchiness in their scars after treatment. Although this laser therapy appears promising, more detailed studies are needed to confirm these benefits. The treatment smooths the skin, making scars less noticeable and more flexible. Participants in this trial will receive treatment on scars located either distal or proximal to the heart to evaluate its effectiveness.46789
Who Is on the Research Team?
S Logsetty, MD
Principal Investigator
University of Manitoba
Are You a Good Fit for This Trial?
This trial is for individuals with burn scars that are 6-12 months old, located on the trunk or limbs. Participants should have a Fitzpatrick skin type I-III and must live in Winnipeg. People with open wounds cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive fractional vascular laser treatment to improve burn scar height, texture, vascularity, and pliability
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Fractional Vascular Laser
Fractional Vascular Laser is already approved in United States, European Union, Canada for the following indications:
- Burn scars
- Hypertrophic scars
- Keloid scars
- Burn scars
- Hypertrophic scars
- Atrophic scars
- Burn scars
- Late burn scars
- Mature scars
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Manitoba
Lead Sponsor